Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn N Waterhouse

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chinese Medicine|December 1, 2009
A novel combination of Chinese medicines to treat advanced cancers and lymphomas in ratsDawn N Waterhouse
Chinese Medicine|March 18, 2010
Retraction. A novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in ratsDawn N Waterhouse
Nanomedicine (London, England)|August 25, 2007
Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapyDawn N Waterhouse, Marcel B Bally
Journal of Experimental Therapeutics & Oncology|December 31, 2003
Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor modelDawn N Waterhouse, Karen A Gelmon, Dana Masin, et al.
Cancer Letters|March 26, 2013
NanotheraputicsM N V Ravi Kumar, Maria J Blanco-Prieto, Dawn N Waterhouse
Nanomedicine (London, England)|November 15, 2011
Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapyDawn N Waterhouse, Donald Yapp, Maite Verreault, et al.
Cancer Biology & Therapy|January 17, 2004
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer modelDawn N Waterhouse, Wieslawa H Dragowska, Karen A Gelmon, et al.
Pharmaceutical Research|June 11, 2005
Trastuzumab and liposomal Doxorubicin in the treatment of mcf-7 xenograft tumor-bearing mice: combination does not affect drug serum levelsDawn N Waterhouse, Tetyana Denyssevych, Norma Hudon, et al.
Methods in Enzymology|February 22, 2005
Preparation, characterization, and biological analysis of liposomal formulations of vincristineDawn N Waterhouse, Thomas D Madden, Pieter R Cullis, et al.
Methods in Enzymology|February 22, 2005
The liposomal formulation of doxorubicinSheela A Abraham, Dawn N Waterhouse, Lawrence D Mayer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chinese Medicine|December 1, 2009
A novel combination of Chinese medicines to treat advanced cancers and lymphomas in ratsDawn N Waterhouse
Chinese Medicine|March 18, 2010
Retraction. A novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in ratsDawn N Waterhouse
Nanomedicine (London, England)|August 25, 2007
Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapyDawn N Waterhouse, Marcel B Bally
Journal of Experimental Therapeutics & Oncology|December 31, 2003
Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor modelDawn N Waterhouse, Karen A Gelmon, Dana Masin, et al.
Cancer Letters|March 26, 2013
NanotheraputicsM N V Ravi Kumar, Maria J Blanco-Prieto, Dawn N Waterhouse
Nanomedicine (London, England)|November 15, 2011
Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapyDawn N Waterhouse, Donald Yapp, Maite Verreault, et al.
Cancer Biology & Therapy|January 17, 2004
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer modelDawn N Waterhouse, Wieslawa H Dragowska, Karen A Gelmon, et al.
Pharmaceutical Research|June 11, 2005
Trastuzumab and liposomal Doxorubicin in the treatment of mcf-7 xenograft tumor-bearing mice: combination does not affect drug serum levelsDawn N Waterhouse, Tetyana Denyssevych, Norma Hudon, et al.
Methods in Enzymology|February 22, 2005
Preparation, characterization, and biological analysis of liposomal formulations of vincristineDawn N Waterhouse, Thomas D Madden, Pieter R Cullis, et al.
Methods in Enzymology|February 22, 2005
The liposomal formulation of doxorubicinSheela A Abraham, Dawn N Waterhouse, Lawrence D Mayer, et al.
Pageof 2